View Item 

Show simple item record

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
dc.contributor.authorTambur, Anat R.
dc.contributor.authorCampbell, Patricia
dc.contributor.authorClaas, Frans H.
dc.contributor.authorFeng, Sandy
dc.contributor.authorGebel, Howard M.
dc.contributor.authorJackson, Annette M.
dc.contributor.authorMannon, Roslyn B.
dc.contributor.authorReed, Elaine F.
dc.contributor.authorTinckam, Kathryn
dc.contributor.authorAskar, Medhat
dc.contributor.authorChandraker, Anil
dc.contributor.authorChang, Patricia P.
dc.contributor.authorColvin, Monica
dc.contributor.authorDemetris, Anthony‐jake
dc.contributor.authorDiamond, Joshua M.
dc.contributor.authorDipchand, Anne I.
dc.contributor.authorFairchild, Robert L.
dc.contributor.authorFord, Mandy L.
dc.contributor.authorFriedewald, John
dc.contributor.authorGill, Ronald G.
dc.contributor.authorGlotz, Denis
dc.contributor.authorGoldberg, Hilary
dc.contributor.authorHachem, Ramsey
dc.contributor.authorKnechtle, Stuart
dc.contributor.authorKobashigawa, Jon
dc.contributor.authorLevine, Deborah J.
dc.contributor.authorLevitsky, Joshua
dc.contributor.authorMengel, Michael
dc.contributor.authorMilford, Edgar
dc.contributor.authorNewell, Kenneth A.
dc.contributor.authorO’leary, Jacqueline G.
dc.contributor.authorPalmer, Scott
dc.contributor.authorRandhawa, Parmjeet
dc.contributor.authorSmith, John
dc.contributor.authorSnyder, Laurie
dc.contributor.authorStarling, Randall C.
dc.contributor.authorSweet, Stuart
dc.contributor.authorTaner, Timucin
dc.contributor.authorTaylor, Craig J.
dc.contributor.authorWoodle, Steve
dc.contributor.authorZeevi, Adriana
dc.contributor.authorNickerson, Peter
dc.date.accessioned2018-07-13T15:48:15Z
dc.date.available2019-09-04T20:15:39Zen
dc.date.issued2018-07
dc.identifier.citationTambur, Anat R.; Campbell, Patricia; Claas, Frans H.; Feng, Sandy; Gebel, Howard M.; Jackson, Annette M.; Mannon, Roslyn B.; Reed, Elaine F.; Tinckam, Kathryn; Askar, Medhat; Chandraker, Anil; Chang, Patricia P.; Colvin, Monica; Demetris, Anthony‐jake ; Diamond, Joshua M.; Dipchand, Anne I.; Fairchild, Robert L.; Ford, Mandy L.; Friedewald, John; Gill, Ronald G.; Glotz, Denis; Goldberg, Hilary; Hachem, Ramsey; Knechtle, Stuart; Kobashigawa, Jon; Levine, Deborah J.; Levitsky, Joshua; Mengel, Michael; Milford, Edgar; Newell, Kenneth A.; O’leary, Jacqueline G. ; Palmer, Scott; Randhawa, Parmjeet; Smith, John; Snyder, Laurie; Starling, Randall C.; Sweet, Stuart; Taner, Timucin; Taylor, Craig J.; Woodle, Steve; Zeevi, Adriana; Nickerson, Peter (2018). "Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report." American Journal of Transplantation 18(7): 1604-1614.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/144684
dc.publisherWiley Periodicals, Inc.
dc.subject.othermonitoring: immune
dc.subject.otheralloantibody
dc.subject.otherclinical research/practice
dc.subject.otherclinical trial design
dc.subject.otherguidelines
dc.subject.otherhistocompatibility
dc.subject.otherimmunobiology
dc.subject.othersensitization
dc.titleSensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144684/1/ajt14752_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/144684/2/ajt14752.pdf
dc.identifier.doi10.1111/ajt.14752
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferenceViglietti D, Loupy A, Aubert O, et al. Dynamic prognostic score to predict kidney allograft survival in patients with antibodyâ mediated rejection. JASN. 2018; 29: 606 â 619.
dc.identifier.citedreferenceDiebolder CA, Beurskens FJ, de Jong RN, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science. 2014; 343 ( 6176 ): 1260 â 1263.
dc.identifier.citedreferenceLan JH, Tinckam K. Clinical utility of complement dependent assays in kidney transplantation. Transplantation. 2018; 102: S14 â S22.
dc.identifier.citedreferenceYell M, Muth BL, Kaufman DB, Djamali A, Ellis TM. C1q binding activity of de novo donorâ specific HLA antibodies in renal transplant recipients with and without antibodyâ mediated rejection. Transplantation. 2015; 99 ( 6 ): 1151 â 1155.
dc.identifier.citedreferenceTambur AR, Wiebe C. HLA diagnoztics: evaluating DSA strength by titration. Transplantation. 2018; 102: S23 â S30.
dc.identifier.citedreferenceTambur AR, Herrera ND, Haarberg KM, et al. Assessing antibody strength: comparison of MFI, C1q, and titer information. Am J Transplant. 2015; 15 ( 9 ): 2421 â 2430.
dc.identifier.citedreferenceReed EF, Rao P, Zhang Z, et al. Comprehensive assessment and standardization of solid phase multiplexâ bead arrays for the detection of antibodies to HLA. Am J Transplant. 2013; 13 ( 7 ): 1859 â 1870.
dc.identifier.citedreferenceLiwski RS, Gebel HM. Of cells and microparticles: assets and liabilities of HLA antibody detection. Transplantation. 2018; 102: S1 â S6.
dc.identifier.citedreferenceClaas FH. Clinical relevance of circulating donorâ specific HLA antibodies. Curr Opin Organ Transplant. 2010; 15 ( 4 ): 462 â 466.
dc.identifier.citedreferenceLucia M, Luque S, Crespo E, et al. Preformed circulating HLAâ specific memory B cells predict high risk of humoral rejection in kidney transplantation. Kidney Int. 2015; 88 ( 4 ): 874 â 887.
dc.identifier.citedreferenceAhmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996; 272 ( 5258 ): 54 â 60.
dc.identifier.citedreferenceAmir AL, Dâ Orsogna LJ, Roelen DL, et al. Alloâ HLA reactivity of virusâ specific memory T cells is common. Blood. 2010; 115 ( 15 ): 3146 â 3157.
dc.identifier.citedreferenceAdams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003; 111 ( 12 ): 1887 â 1895.
dc.identifier.citedreferenceSallusto F, Lanzavecchia A, Araki K, Ahmed R. From vaccines to memory and back. Immunity. 2010; 33 ( 4 ): 451 â 463.
dc.identifier.citedreferenceVisentin J, Vigata M, Daburon S, et al. Deciphering complement interference in antiâ human leukocyte antigen antibody detection with flow beads assays. Transplantation. 2014; 98 ( 6 ): 625 â 631.
dc.identifier.citedreferenceTambur AR, Rosati J, Roitberg S, Glotz D, Friedewald JJ, Leventhal JR. Epitope analysis of HLAâ DQ antigens: what does the antibody see? Transplantation. 2014; 98 ( 2 ): 157 â 166.
dc.identifier.citedreferenceWeitzner BD, Dunbrack RL Jr, Gray JJ. The origin of CDR H3 structural diversity. Structure. 2015; 23 ( 2 ): 302 â 311.
dc.identifier.citedreferenceWiebe C, Gareau AJ, Pochinco D, et al. Evaluation of C1q status and titer of de novo donorâ specific antibodies as predictors of allograft survival. Am J Transplant. 2017; 17 ( 3 ): 703 â 711.
dc.identifier.citedreferenceAubert O, Loupy A, Hidalgo L, et al. Antibodyâ mediated rejection due to preexisting versus de novo donorâ specific antibodies in kidney allograft recipients. J Am Soc Nephrol. 2017; 28 ( 6 ): 1912 â 1923.
dc.identifier.citedreferenceHricik DE, Formica RN, Nickerson P, et al. Adverse outcomes of tacrolimus withdrawal in immuneâ quiescent kidney transplant recipients. J Am Soc Nephrol. 2015; 26 ( 12 ): 3114 â 3122.
dc.identifier.citedreferenceDugast E, Soulillou JP, Foucher Y, et al. Failure of calcineurin inhibitor (tacrolimus) weaning randomized trial in longâ term stable kidney transplant recipients. Am J Transplant. 2016; 16 ( 11 ): 3255 â 3261.
dc.identifier.citedreferenceGloor JM, Winters JL, Cornell LD, et al. Baseline donorâ specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant. 2010; 10 ( 3 ): 582 â 589.
dc.identifier.citedreferenceValenzuela NM, Schaub S. The biology of IgG subclasses and their clinical relevance to transplantation. Transplantation 2018; 1S ( suppl 1 ): S7 â S13.
dc.identifier.citedreferenceSethi S, Choi J, Toyoda M, Vo A, Peng A, Jordan SC. Desensitization: overcoming the immunologic barriers to transplantation. J Immunol Res. 2017; 2017: 6804678.
dc.identifier.citedreferenceWoodle ES, Shields AR, Ejaz NS, et al. Prospective iterative trial of proteasome inhibitorâ based desensitization. Am J Transplant. 2015; 15 ( 1 ): 101 â 118.
dc.identifier.citedreferenceVo AA, Choi J, Kim I, et al. A phase I/II trial of the interleukinâ 6 receptorâ specific humanized monoclonal (tocilizumab) + intravenous immunoglobulin in difficult to desensitize patients. Transplantation. 2015; 99 ( 11 ): 2356 â 2363.
dc.identifier.citedreferenceMontgomery RA, Lonze BE, King KE, et al. Desensitization in HLAâ incompatible kidney recipients and survival. N Engl J Med. 2011; 365 ( 4 ): 318 â 326.
dc.identifier.citedreferenceKosmoliaptsis V, Mallon DH, Chen Y, Bolton EM, Bradley JA, Taylor CJ. Alloantibody responses after renal transplant failure can be better predicted by donorâ recipient HLA amino acid sequence and physicochemical disparities than conventional HLA matching. Am J Transplant. 2016; 16 ( 7 ): 2139 â 2147.
dc.identifier.citedreferenceWiebe C, Nickerson P. Strategic use of epitope matching to improve outcomes. Transplantation. 2016; 100 ( 10 ): 2048 â 2052.
dc.identifier.citedreferenceWiebe C, Pochinco D, Blydtâ Hansen TD, et al. Class II HLA epitope matchingâ A strategy to minimize de novo donorâ specific antibody development and improve outcomes. Am J Transplant. 2013; 13 ( 12 ): 3114 â 3122.
dc.identifier.citedreferenceHaas M, Mirocha J, Reinsmoen NL, et al. Differences in pathologic features and graft outcomes in antibodyâ mediated rejection of renal allografts due to persistent/recurrent versus de novo donorâ specific antibodies. Kidney Int. 2017; 91 ( 3 ): 729 â 737.
dc.identifier.citedreferenceDavis S, Gralla J, Klem P, et al. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donorâ specific antibodies in the first year of kidney transplantation. Am J Transplant. 2018; 18 ( 4 ): 907 â 915.
dc.identifier.citedreferenceWiebe C, Rush DN, Nevins TE, et al. Class II eplet mismatch modulates tacrolimus trough levels required to prevent donorâ specific antibody development. J Am Soc Nephrol. 2017; 28 ( 11 ): 3353 â 3362.
dc.identifier.citedreferenceGatault P, Kamar N, Buchler M, et al. Reduction of extendedâ release tacrolimus dose in lowâ immunologicalâ risk kidney transplant recipients increases risk of rejection and appearance of donorâ specific antibodies: a randomized study. Am J Transplant. 2017; 17 ( 5 ): 1370 â 1379.
dc.identifier.citedreferenceHricik DE, Rodriguez V, Riley J, et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferonâ gamma independently predicts renal function in kidney transplant recipients. Am J Transplant. 2003; 3 ( 7 ): 878 â 884.
dc.identifier.citedreferenceMulder A, Eijsink C, Kardol MJ, et al. Identification, isolation, and culture of HLAâ A2â specific B lymphocytes using MHC class I tetramers. J Immunol. 2003; 171 ( 12 ): 6599 â 6603.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajt14752_am.pdf
Size:
266.0KB
Format:
PDF
View/Open
Name:
ajt14752.pdf
Size:
1.743MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.